The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Localized scleroderma: clinical spectrum and therapeutic update
Open accessAbstract
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma. In this review, we report the most important aspects and particularities in the treatment of patients diagnosed with localized scleroderma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermatology in General Medicine.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_2 · Cited by 1,237
Clements, P. J., Lachenbruch, P. A., Siebold, J., White, B., Weiner, S. J., Martin, R. W., Weinstein, A., Weisman, M. H., Mayes, M. D., & Collier, D. H. (1995) · PubMed · Cited by 874
Fett, N., & Werth, V. P. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.05.045 · Cited by 394
The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993.
Peterson, L. S., Nelson, A. M., Su, W. P. D., et al. (1997) · PubMed · Cited by 366
Localized scleroderma in childhood is not just a skin disease
Zulian, F., Vallongo, C., Woo, P., Russo, R., Ruperto, N., Harper, J., Espada, G., Corona, F., Mukamel, M., Vesely, R., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21264 · Cited by 364
The Pathogenesis of Systemic Sclerosis
Katsumoto, T. R., Whitfield, M. L., & Connolly, M. K. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130312 · Cited by 313
Arnett, F. C., Cho, M., Chatterjee, S., Aguilar, M. B., Reveille, J. D., & Mayes, M. D. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200106)44:6<1359::aid-art228>3.0.co;2-s · Cited by 294
Distinct Autoimmune Syndromes in Morphea: A Review of 245 Adult and Pediatric Cases
Leitenberger, J. J., Cayce, R. L., Haley, R. W., Adams-Huet, B., Bergstresser, P. R., & Jacobe, H. T. (2009) · Archives of Dermatology · doi:10.1001/archdermatol.2009.79 · Cited by 259
Textbook of Pediatric Rheumatology
Wallace, C. A. (2002) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.156.3.299 · Cited by 253
Kreuter, A., Hyun, J., Stücker, M., Sommer, A., Altmeyer, P., & Gambichler, T. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.11.1063 · Cited by 249
Zulian, F., Martini, G., Vallongo, C., Vittadello, F., Falcini, F., Patrizi, A., Alessio, M., Torre, F. L., Podda, R. A., Gerloni, V., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30264 · Cited by 216
Weibel, L., Sampaio, M. C., Visentin, M. T., Howell, K. J., Woo, P., & Harper, J. I. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07497.x · Cited by 216
Topical calcipotriene for morphea/linear scleroderma
Cunningham, B. B., Landells, I. D. R., Langman, C., Sailer, D. E., & Paller, A. S. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70077-5 · Cited by 193
Neurologic manifestations of localized scleroderma: A case report and literature review
Kister, I., Inglese, M., Laxer, R. M., & Herbert, J. (2008) · Neurology · doi:10.1212/01.wnl.0000334474.88923.e3 · Cited by 160
Systemic and localized scleroderma
Chung, L. S., Lin, J., Furst, D. E., & Fiorentino, D. F. (2006) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2006.07.004 · Cited by 144
Hulshof, M. M., Bavinck, J. N. B., Bergman, W. A., et al. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.108369 · Cited by 130
Antinuclear and Anti-Single-Stranded DNA Antibodies in Morphea and Generalized Morphea
Falanga, V. (1987) · Archives of Dermatology · doi:10.1001/archderm.1987.01660270088021 · Cited by 107
Neurologic Manifestations of Connective Tissue Disease
Nadeau, S. E. (2002) · Neurologic Clinics · doi:10.1016/s0733-8619(03)00057-4 · Cited by 86
Li, S. C., Feldman, B. M., Higgins, G. C., HAINES, K. A., Punaro, M., & O’Neil, K. M. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090708 · Cited by 82
Autoantibodies in Parry-Romberg syndrome: a serologic study of 14 patients.
Torre, I. G.-D. L., Castello-Sendra, J., Esgleyes-Ribot, T., et al. (1995) · PubMed · Cited by 78
Morphea and localized scleroderma in children
Vierra, E., & Cunningham, B. B. (1999) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/s1085-5629(99)80019-4 · Cited by 57
Progressive facial hemiatrophy and epilepsy
Dupont, S., Catala, M., Hasboun, D., Semah, F., & Baulac, M. (1997) · Neurology · doi:10.1212/wnl.48.4.1013 · Cited by 56
Uziel, Y., Miller, M. L., & Laxer, R. M. (1995) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(16)40058-1 · Cited by 56
Imatinib treatment of generalized localized scleroderma (morphea)
Moinzadeh, P., Krieg, T. M., & Hunzelmann, N. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.02.030 · Cited by 37
Cited by
Application of an iPSC‐Derived Organoid Model for Localized Scleroderma Therapy
Ma, J., Li, W., Cao, R., Gao, D., Zhang, Q., Li, X., Li, B., Lv, L., Li, M., Jiang, J., et al. (2022) · Advanced Science · doi:10.1002/advs.202106075 · Cited by 38
Metadata
- Authors
- Careta, M. F., & Romiti, R.
- Venue
- Anais Brasileiros de Dermatologia
- Publisher
- FapUNIFESP (SciELO)
- Published
- 2015-02
- Volume
- 90
- Issue
- 1
- Pages
- 62-73
- ISSN
- 0365-0596 (ISSN-L)
- OpenAlex
- W2037245410
- Cited by
- 259
- References
- 24
- FWCI
- 11.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.